# Fiona Blackhall

Source: https://onco.cc/people/fiona-blackhall/  
OnCo record `fiona-blackhall` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Fiona Blackhall is a thoracic oncologist leading small-cell lung cancer trials and biomarker research at The Christie.

## Summary

Fiona Blackhall is Professor of Thoracic Oncology at the University of Manchester and a consultant at The Christie NHS Foundation Trust. Her specialisms are lung cancer, small-cell lung cancer and biomarker-driven trials. She leads thoracic oncology research in Manchester with trials in small-cell and non-small-cell lung cancer and studies of blood-based biomarkers. Her papers include an analysis of the prognostic value of circulating tumour cells in limited-stage small-cell lung cancer within the CONVERT radiotherapy trial, the randomised ERCC1 biomarker trial comparing platinum and non-platinum therapy in advanced non-small-cell lung cancer, and a review of liquid biopsy as a route to improved care in small-cell lung cancer. Her publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Thoracic Oncology, University of Manchester; Consultant, The Christie
- Specialisms: Lung cancer; Small-cell lung cancer; Biomarker-driven trials

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Blackhall%20F%5BAuthor%5D%20small%20cell%20lung

## Connected records

- cancers: [Limited-stage small-cell lung cancer](https://onco.cc/cancers/limited-stage-sclc/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- institutions: [Cancer Research UK Manchester Institute](https://onco.cc/institutions/cruk-manchester-institute/), [International Association for the Study of Lung Cancer](https://onco.cc/institutions/iaslc/), [The Christie NHS Foundation Trust](https://onco.cc/institutions/the-christie/)
- ideas: [Grow blood-borne tumour cells to test drugs on the cells that actually spread](https://onco.cc/ideas/idea-bio2-ctc-culture-functional-testing/)
- key papers: [DeLLphi-301: tarlatamab, a DLL3-targeting T-cell engager, in previously treated small-cell lung cancer](https://onco.cc/key-papers/paper-dellphi-301-nejm-2023/)

---
JSON: https://onco.cc/api/v1/entities/fiona-blackhall.json